Net Income

As its new obesity drug enters a key trial, Biohaven bets on a novel approach: reducing fat while preserving precious muscle mass. Can it redefine weight loss?

Net Lease Office Properties rewards shareholders with a $3.30 special dividend, funded by property sales, amid a challenging office real estate market.

China's MRO giant ZKH Group returns to profitability, fueled by a surge in customers, AI automation, and an aggressive international expansion strategy.

Belief BioMed's single-dose treatment for hemophilia B, BBM-H901, is now approved in Macao, offering a new horizon for patients beyond frequent injections.

Despite new regulations, LexinFintech's 2025 net profit surged 52.4%. See how risk management and a booming e-commerce arm fueled its resilience.

Silicom is set to meet investors, highlighting a return to growth and its expanding AI-inference solutions. Is this the start of a major turnaround?

As costs soar, Angle Health's new webinar series brings in top experts to offer brokers and employers actionable strategies on everything from pharmacy spend to AI.

Centre for Neuro Skills appoints Jay Varma to lead a new employer partnership strategy, signaling a major shift in managing workforce neurological health.

Woodrow AI has launched a specialized agent for finance teams, promising the accuracy and audit trails that have kept AI out of the back office until now.

A new centralized safety shoe program aims to reduce injuries, cut insurance costs, and retain essential workers in the challenged multifamily sector.

Amidst market chaos, a trader delivered a 25% return in two months. Here's how EverForward Trading's unique risk-first model made it possible.

A $15.5M patent sale masks falling revenues, funding a critical pivot to the competitive in-cabin sensing market. Can Neonode's new focus pay off?

The creator of Mobile Legends is betting billions on a new universe of film and TV IPs, but can it succeed in a market of giants?

Red Light Holland is deploying advanced AI from Kala Bio to accelerate its botanical psilocybin program, signaling a new high-tech era for mental health.

A new 720 kW rooftop solar project at a Mercedes-Benz facility in California highlights a strategic shift for businesses seeking cost control and resilience.

With fresh funding secured, Dogwood Therapeutics pushes its promising nerve pain drug, Halneuron®, toward a pivotal data readout later this year.

In a bid to bolster US energy security, Eagle Nuclear hires SLR to navigate permitting for its Aurora project, aiming for FAST-41 status.

A triple win from Black Book Research for IKS Health isn't just a trophy; it's proof that AI is now the backbone of modern healthcare revenue and operations.

With a major Series B financing, Crossbow advances its TCR-mimetic therapies, aiming to unlock a new frontier in the fight against a broad range of cancers.

Dr. Toyin Ajayi's board appointment signals a major strategic move to integrate nutrition into healthcare for America's most vulnerable populations.